Alexandru Daniel Radu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandru Daniel Radu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Angela-Ștefania Marghescu
Pathological Anatomy Discipline, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
3 shared publications - Beatrice Mahler
Cardiothoracic Department, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania
3 shared publications - Cristina Teleagă
Research Department, “Marius Nasta” Institute of Pulmonology, 050159 Bucharest, Romania
3 shared publications - Alexandru Stoichiță
Department of Pneumology, “Marius Nasta” National Institute of Pneumology, 050150 Bucharest, Romania
2 shared publications - Mariana Costache
Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
2 shared publications - Mirela Țigău
Department of Research, Marius Nasta Institute of Pneumophthisiology, 050159 Bucharest, Romania
2 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Published by MDPI AG in Journal of Respiration
- Vol. 6 (1) , 4
Post-COVID-19 Cardiovascular Complications: An Updated Systematic Review
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can cause persistent, multisystem complications collectively termed long COVID. Cardiovascular sequelae are among the most clinically significant yet remain incompletely characterized. This review aimed to synthesize current evidence on objective cardiovascular outcomes in long COVID and explore underlying mechanisms. Methods: A systematic review was conducted using PubMed, Scopus, and Web of Science for studies published between January 2020 and March 2024. Search terms included “COVID-19,” “long COVID,” “post-acute sequelae,” “cardiovascular,” “echocardiography,” “biomarkers,” and “imaging.” Only studies reporting at least one cardiovascular outcome, defined as either objectively measured parameters (e.g., echocardiography, cardiac biomarkers, ECG findings, or vascular function indices) or clinically relevant cardiovascular symptoms during follow-up, were included. From 412 identified records, ten recent, high-quality studies with a primary cardiovascular focus were selected. This systematic review was conducted in accordance with the PRISMA 2020 guidelines. Results: Long COVID is associated with subclinical myocardial dysfunction, arrhythmias, endothelial injury, vascular stiffness, and a prothrombotic state. Reported findings included reduced left ventricular ejection fraction, impaired global longitudinal strain, increased arterial stiffness, elevated cardiac biomarkers, new-onset hypertension, and persistent ECG changes, even in non-hospitalized patients without prior cardiovascular disease. Proposed mechanisms include myocardial inflammation, endothelial dysfunction, renin–angiotensin–aldosterone system dysregulation, autonomic imbalance, and chronic inflammation. Secondary bacterial and fungal infections were noted in critically ill survivors but did not fully explain the breadth or persistence of symptoms. Conclusions: Long COVID is a heterogeneous entity with substantial cardiovascular implications across all levels of acute disease severity. Early detection through longitudinal monitoring, standardized definitions, and multidisciplinary care is essential to reduce long-term cardiovascular risk.
- 25 February 2026
- Published by MDPI AG in Journal of Respiration
- Vol. 6 (1) , 4
Open AccessPost-COVID-19 Cardiovascular Complications: An Updated Systematic Review
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can cause persistent, multisystem complications collectively termed long COVID. Cardiovascular sequelae are among the most clinically significant yet remain incompletely characterized. This review aimed to synthesize current evidence on objective cardiovascular outcomes in long COVID and explore underlying mechanisms. Methods: A systematic review was conducted using PubMed, Scopus, and Web of Science for studies published between January 2020 and March 2024. Search terms included “COVID-19,” “long COVID,” “post-acute sequelae,” “cardiovascular,” “echocardiography,” “biomarkers,” and “imaging.” Only studies reporting at least one cardiovascular outcome, defined as either objectively measured parameters (e.g., echocardiography, cardiac biomarkers, ECG findings, or vascular function indices) or clinically relevant cardiovascular symptoms during follow-up, were included. From 412 identified records, ten recent, high-quality studies with a primary cardiovascular focus were selected. This systematic review was conducted in accordance with the PRISMA 2020 guidelines. Results: Long COVID is associated with subclinical myocardial dysfunction, arrhythmias, endothelial injury, vascular stiffness, and a prothrombotic state. Reported findings included reduced left ventricular ejection fraction, impaired global longitudinal strain, increased arterial stiffness, elevated cardiac biomarkers, new-onset hypertension, and persistent ECG changes, even in non-hospitalized patients without prior cardiovascular disease. Proposed mechanisms include myocardial inflammation, endothelial dysfunction, renin–angiotensin–aldosterone system dysregulation, autonomic imbalance, and chronic inflammation. Secondary bacterial and fungal infections were noted in critically ill survivors but did not fully explain the breadth or persistence of symptoms. Conclusions: Long COVID is a heterogeneous entity with substantial cardiovascular implications across all levels of acute disease severity. Early detection through longitudinal monitoring, standardized definitions, and multidisciplinary care is essential to reduce long-term cardiovascular risk.
- Open Access
- 11 October 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (20) , 2264
How Morphology Shapes Survival in Invasive Squamous Cell Carcinoma of the Lung
Background and Objectives: Squamous cell carcinoma (SQCC) represents a significant proportion of human malignancies affecting various anatomical sites, including the lung. Understanding the prognostic factors is crucial for establishing effective risk stratification in these patients, as multiple critical aspects significantly impact overall survival. Materials and Methods: A retrospective study was conducted on 99 patients with operable lung SQCC treated at a tertiary center. The exclusion criteria included patients under 18, those with in situ or metastatic SQCC, and those who received neoadjuvant therapy. The surgical specimens were re-analyzed, and data were collected on multiple variables, including pTNM staging, tumor characteristics, and overall survival (OS). The Kaplan–Meier survival analysis and Cox regression models were used to identify significant prognostic factors. Results: The Kaplan–Meier analysis showed a median survival of 36 months with a 65.65% mortality rate. Significant factors influencing survival included keratinization, histological grading, tumor size and stage, pleural invasion, tumor cell arrangement, tumor budding, spread through air space (STAS), and mitotic index. A multiple Cox regression highlighted the nonkeratinizing tumors, advanced pT stages, single-cell invasion, and high mitotic index as key predictors of poorer outcomes. The nonkeratinizing tumors showed higher mortality and shorter median survival rates compared to keratinizing tumors. The tumor staging, cell arrangement, and tumor budding significantly impacted the survival curves. Conclusions: The study underscores the importance of detailed histopathological evaluations in lung SQCC. The nonkeratinizing tumors, advanced pT stage, single-cell invasion, and high mitotic index were associated with higher hazard rates, emphasizing the need for a comprehensive grading system incorporating these factors to improve prognostic accuracy and guide treatment strategies.
- 11 October 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (20) , 2264
Open AccessHow Morphology Shapes Survival in Invasive Squamous Cell Carcinoma of the Lung
Background and Objectives: Squamous cell carcinoma (SQCC) represents a significant proportion of human malignancies affecting various anatomical sites, including the lung. Understanding the prognostic factors is crucial for establishing effective risk stratification in these patients, as multiple critical aspects significantly impact overall survival. Materials and Methods: A retrospective study was conducted on 99 patients with operable lung SQCC treated at a tertiary center. The exclusion criteria included patients under 18, those with in situ or metastatic SQCC, and those who received neoadjuvant therapy. The surgical specimens were re-analyzed, and data were collected on multiple variables, including pTNM staging, tumor characteristics, and overall survival (OS). The Kaplan–Meier survival analysis and Cox regression models were used to identify significant prognostic factors. Results: The Kaplan–Meier analysis showed a median survival of 36 months with a 65.65% mortality rate. Significant factors influencing survival included keratinization, histological grading, tumor size and stage, pleural invasion, tumor cell arrangement, tumor budding, spread through air space (STAS), and mitotic index. A multiple Cox regression highlighted the nonkeratinizing tumors, advanced pT stages, single-cell invasion, and high mitotic index as key predictors of poorer outcomes. The nonkeratinizing tumors showed higher mortality and shorter median survival rates compared to keratinizing tumors. The tumor staging, cell arrangement, and tumor budding significantly impacted the survival curves. Conclusions: The study underscores the importance of detailed histopathological evaluations in lung SQCC. The nonkeratinizing tumors, advanced pT stage, single-cell invasion, and high mitotic index were associated with higher hazard rates, emphasizing the need for a comprehensive grading system incorporating these factors to improve prognostic accuracy and guide treatment strategies.
- Open Access
Atypical Histopathological Aspects of Common Types of Lung Cancer—Our Experience and Literature Review
Lung cancer is among the most common oncological diseases regarding incidence and mortality, with most of these having epithelial origins. Pathological reporting of these tumors is conducted according to the 5th edition of the World Health Organisation (WHO) classification of thoracic tumours. This study aims to draw the pathologist’s attention to four rare, atypical microscopic aspects that some of the most common types of lung malignancies reveal upon standard evaluation (hematoxylin-eosin stain) that make histopathological diagnosis challenging: acantholytic, pseudoangiosarcomatous, signet ring cell, and clear cell features. Each of these aspects was exemplified by a case diagnosed in the pathology department of the “Marius Nasta” Institute. Furthermore, we analyzed the classification dynamics of different WHO editions and used PubMed to review articles written in English and published in the last eleven years on this subject. Pathologists should be familiar with these unusual aspects to avoid misdiagnoses and to ensure the correct classification of tumors, which is extremely important because these tumor phenotypes have been associated with specific molecular alterations and a worse clinical evolution. There is a need to clarify the histogenesis and associated genetic mutations, given the fact that the rarity of these tumor phenotypes makes their study difficult. Some authors consider these to be overlapping entities; however, we do not encourage this, as they may exhibit different prognoses and various molecular alterations with important therapeutic implications. The signet ring cell feature was associated with ALK rearrangement in lung adenocarcinoma; thus, these patients can benefit from tailored therapy with ALK-tyrosine kinase inhibitors (ALK-TKI). Recent studies associated clear cell morphology with FGFR3-TACC3 fusion, suggesting that patients with this diagnosis may be potentially eligible for FGFR inhibitors. We described, for the first time, the pseudoangiosarcomatous pattern in a case of lung adenocarcinoma; to our knowledge this aspect has only been described until now in the context of squamous cell carcinomas.
Open AccessAtypical Histopathological Aspects of Common Types of Lung Cancer—Our Experience and Literature Review
Lung cancer is among the most common oncological diseases regarding incidence and mortality, with most of these having epithelial origins. Pathological reporting of these tumors is conducted according to the 5th edition of the World Health Organisation (WHO) classification of thoracic tumours. This study aims to draw the pathologist’s attention to four rare, atypical microscopic aspects that some of the most common types of lung malignancies reveal upon standard evaluation (hematoxylin-eosin stain) that make histopathological diagnosis challenging: acantholytic, pseudoangiosarcomatous, signet ring cell, and clear cell features. Each of these aspects was exemplified by a case diagnosed in the pathology department of the “Marius Nasta” Institute. Furthermore, we analyzed the classification dynamics of different WHO editions and used PubMed to review articles written in English and published in the last eleven years on this subject. Pathologists should be familiar with these unusual aspects to avoid misdiagnoses and to ensure the correct classification of tumors, which is extremely important because these tumor phenotypes have been associated with specific molecular alterations and a worse clinical evolution. There is a need to clarify the histogenesis and associated genetic mutations, given the fact that the rarity of these tumor phenotypes makes their study difficult. Some authors consider these to be overlapping entities; however, we do not encourage this, as they may exhibit different prognoses and various molecular alterations with important therapeutic implications. The signet ring cell feature was associated with ALK rearrangement in lung adenocarcinoma; thus, these patients can benefit from tailored therapy with ALK-tyrosine kinase inhibitors (ALK-TKI). Recent studies associated clear cell morphology with FGFR3-TACC3 fusion, suggesting that patients with this diagnosis may be potentially eligible for FGFR inhibitors. We described, for the first time, the pseudoangiosarcomatous pattern in a case of lung adenocarcinoma; to our knowledge this aspect has only been described until now in the context of squamous cell carcinomas.
- 30 December 2023
- Published by Institutul National de Cercetare Dezvoltare Medico-Militara "Cantacuzino" in Romanian Archives of Microbiology and Immunology
- Vol. 82 (4) , 267-272
NEW TREATMENT METHODS OF SARCOIDOSIS: NARRATIVE REVIEW
Multiple organs are affected by the systemic, granulomatous disease known as sarcoidosis, which has an unpredictable clinical course and an unclear etiology. Systemic therapy is required for approximately 50% of patients with sarcoidosis to treat their illness. The usual first-line treatment for sarcoidosis is oral glucocorticoids. Long-term high-dose use may cause significant morbidity in patients over time. We searched the PubMed database for articles about randomized controlled trials involving novel treatments for sarcoidosis conducted over ten years between 2012 and 2021. We looked for information on novel treatments and strategies for treating pulmonary sarcoidosis. Out of the 26 entries, the search yielded, we chose 11 studies that we thought were pertinent and served as the foundation for this analysis. (("Sarcoidosis treatment"[Mesh]) AND "Pulmonary sarcoidosis"[Mesh]) were the search terms used. Diagnosing sarcoidosis, developing therapeutic behavior, overseeing long-term treatment, and ensuring patient compliance are all very challenging. Although it is difficult to predict how the disease will progress, more than half of the cases have the possibility of remission. Multidisciplinary studies are still required to test new drugs.
- 30 December 2023
- Published by Institutul National de Cercetare Dezvoltare Medico-Militara "Cantacuzino" in Romanian Archives of Microbiology and Immunology
- Vol. 82 (4) , 267-272
NEW TREATMENT METHODS OF SARCOIDOSIS: NARRATIVE REVIEW
Multiple organs are affected by the systemic, granulomatous disease known as sarcoidosis, which has an unpredictable clinical course and an unclear etiology. Systemic therapy is required for approximately 50% of patients with sarcoidosis to treat their illness. The usual first-line treatment for sarcoidosis is oral glucocorticoids. Long-term high-dose use may cause significant morbidity in patients over time. We searched the PubMed database for articles about randomized controlled trials involving novel treatments for sarcoidosis conducted over ten years between 2012 and 2021. We looked for information on novel treatments and strategies for treating pulmonary sarcoidosis. Out of the 26 entries, the search yielded, we chose 11 studies that we thought were pertinent and served as the foundation for this analysis. (("Sarcoidosis treatment"[Mesh]) AND "Pulmonary sarcoidosis"[Mesh]) were the search terms used. Diagnosing sarcoidosis, developing therapeutic behavior, overseeing long-term treatment, and ensuring patient compliance are all very challenging. Although it is difficult to predict how the disease will progress, more than half of the cases have the possibility of remission. Multidisciplinary studies are still required to test new drugs.
- 30 September 2022
- Published by Institutul National de Cercetare Dezvoltare Medico-Militara "Cantacuzino" in Romanian Archives of Microbiology and Immunology
- Vol. 81 (3) , 214-221
"THE RISK FACTORS RESPONSIBLE FOR THE OCCURRENCE OF PNEUMOCYSTIS PNEUMONIA: NARRATIVE REVIEW"
- 30 September 2022
- Published by Institutul National de Cercetare Dezvoltare Medico-Militara "Cantacuzino" in Romanian Archives of Microbiology and Immunology
- Vol. 81 (3) , 214-221
"THE RISK FACTORS RESPONSIBLE FOR THE OCCURRENCE OF PNEUMOCYSTIS PNEUMONIA: NARRATIVE REVIEW"
- 31 March 2022
- Published by Institutul National de Cercetare Dezvoltare Medico-Militara "Cantacuzino" in Romanian Archives of Microbiology and Immunology
- Vol. 81 (1) , 38-44
HEALTHCARE ASSOCIATED INFECTIONS IN INTENSIVE CARE UNITS
Mădălina "Hospital-acquired infections (HAIs) are the infections that develop clinically after 48 hours of admission in the hospital. Nosocomial infections occur within 48-72 hours of admission and are characterized by significantly higher incidence of infections resistant to treatment. Exogenous or endogenous pathogenic microorganisms can cause healthcare-associated illnesses. The clinical expertise of senior physicians and some prior studies indicated that the risk factors for HAI included both the patients own characteristics, as well as extrinsic factors. Patients’ characteristics may include age, sex, body weight, intrinsic comorbidities, diabetes mellitus, and immunological factors, while external factors may be represented by invasive procedures, medications, mechanical ventilation, surgery time in minutes, reoperation, cephalosporin exposure, days of exposure to central venous catheter, and stays in intensive care units. Monitoring of HAIs and application of preventive measures are essential in order to lower their incidence. Keywords: healthcare associated infections, intensive care unit"
- 31 March 2022
- Published by Institutul National de Cercetare Dezvoltare Medico-Militara "Cantacuzino" in Romanian Archives of Microbiology and Immunology
- Vol. 81 (1) , 38-44
HEALTHCARE ASSOCIATED INFECTIONS IN INTENSIVE CARE UNITS
Mădălina "Hospital-acquired infections (HAIs) are the infections that develop clinically after 48 hours of admission in the hospital. Nosocomial infections occur within 48-72 hours of admission and are characterized by significantly higher incidence of infections resistant to treatment. Exogenous or endogenous pathogenic microorganisms can cause healthcare-associated illnesses. The clinical expertise of senior physicians and some prior studies indicated that the risk factors for HAI included both the patients own characteristics, as well as extrinsic factors. Patients’ characteristics may include age, sex, body weight, intrinsic comorbidities, diabetes mellitus, and immunological factors, while external factors may be represented by invasive procedures, medications, mechanical ventilation, surgery time in minutes, reoperation, cephalosporin exposure, days of exposure to central venous catheter, and stays in intensive care units. Monitoring of HAIs and application of preventive measures are essential in order to lower their incidence. Keywords: healthcare associated infections, intensive care unit"